Cheryl Potter, MD
Obstetrics & Gynecology · Rockwall, TXNPI 1982693578
Payments from drug & device makers
Across 224 payments — averaging $18.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$594
- Sumitomo Pharma America, Inc.$433
- Millicent US Inc$391
- Astellas Pharma US Inc$311
- Exeltis, USA Inc.$259
- Therapeuticsmd, Inc.$232
- plus $2K from 32 others
What the payments were for
- Food & beverage$3,99698%
- Education$652%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 36 | $594 |
| Sumitomo Pharma America, Inc. | 36 | $433 |
| Millicent US Inc | 21 | $391 |
| Astellas Pharma US Inc | 11 | $311 |
| Exeltis, USA Inc. | 14 | $259 |
| Therapeuticsmd, Inc. | 15 | $232 |
| Pfizer | 8 | $170 |
| Avion Pharmaceuticals | 8 | $122 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $109 |
| Bayer | 6 | $106 |
| Agile Therapeutics, Inc. | 5 | $101 |
| Johnson & Johnson | 4 | $94 |
| Minerva Surgical, Inc | 3 | $93 |
| Shield Therapeutics Inc | 2 | $92 |
| Myovant Sciences Inc. | 5 | $83 |
| Mayne Pharma Commercial LLC | 3 | $70 |
| Hologic Sales And Service, LLC | 2 | $69 |
| AMAG Pharmaceuticals, Inc. | 5 | $65 |
| Axonics, Inc. | 3 | $62 |
| Evofem Biosciences, Inc. | 3 | $61 |
| Baxter Healthcare | 3 | $60 |
| Medtronic | 2 | $46 |
| Merck | 2 | $43 |
| Mylan Pharmaceuticals Inc. | 2 | $41 |
| Lupin Inc. | 3 | $40 |
| BD | 2 | $35 |
| Aspira Women's Health Inc | 2 | $34 |
| Organon | 1 | $30 |
| Myriad Women's Health, Inc. | 1 | $29 |
| Meditrina | 2 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Vertical Pharmaceuticals, LLC | 1 | $24 |
| Exact Sciences | 1 | $23 |
| Mycovia Pharmaceuticals, Inc. | 1 | $20 |
| Davol Inc. | 1 | $20 |
| Boston Scientific | 1 | $19 |
| Duchesnay USA Incorporated | 1 | $14 |
| Convatec Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veozah$122
How this compares
$4,061 in reported general payments places this provider in the 80th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 11 | $5,179 |
| PremarinEstrogens, Conjugated | 12 | $4,161 |
| Estradiol | 137 | $2,982 |
| Estradiol (Once Weekly)Estradiol | 33 | $2,270 |
| ProgesteroneProgesterone, Micronized | 36 | $1,518 |
| Estradiol (Twice Weekly)Estradiol | 11 | $1,384 |
| Clobetasol Propionate | 16 | $324 |
| ValacyclovirValacyclovir Hcl | 15 | $254 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $433 | $5,17911 claims |
| PfizerPremarin | $170 | $4,16112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,099 obstetrics & gynecology providers in Texas.
Other obstetrics & gynecology in Rockwall
- Amir JazaeriHouston$19.5M
- Shannon WestinHouston$17.3M
- Monica LopezFort Worth$8.1M
- Cynthia RobbinsFort Worth$7.8M
- John Paul RobertsPlano$4.9M
- Stephen StamatisWeatherford$4.5M
- Parke HedgesSan Antonio$4.2M
- Mary MartinBeaumont$2.8M
- Mark JacobsHouston$2.8M
- Dawnette PepplerArlington$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.